BDX stock: buy or sell?
August 22nd, 2019
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products worldwide.
Should I buy BDX stock?Make a decision about when to buy or sell stocks is one of the hardest parts of being a trader or investor. Trading strategies are meant for helping you in the decision process of what stocks to choose and when is the best time to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.
Currently, Becton, Dickinson and stock doesn't match any of these trading strategies, so our recommendation is not to buy.
|New all-time high||No|
|New 52 week high||No|
|Price crossing up 200d MA||No|
|100d MA crossing up 200d MA||No|
Is Becton, Dickinson and stock a buy?
Everyday, hundreds of stock ratings are published by financial analysts to indicate a particular stock's attractiveness.At Stocks2.com, we collected 13 ratings published for BDX stock in the last 30 days. The general sentiment of these ratings is bullish for BDX stock, with 6 positive ratings.
|Date||Analyst / Broker||Previous rating||Current rating|
|2019-8-6||Piper Jaffray Companies||n/a||Overweight|
|2019-7-16||Morgan Stanley||n/a||Equal Weight|
|2019-5-13||Wells Fargo & Co||n/a||Outperform|
|2019-5-10||Morgan Stanley||n/a||Equal Weight|
|2019-4-15||Barclays||Equal Weight||Equal Weight|
|2019-2-5||Piper Jaffray Companies||n/a||Overweight|
|2019-1-2||Morgan Stanley||Equal Weight||Equal Weight|
BDX stock analysis
Shares of Becton, Dickinson and ended today at $255.18 and stepped up a slightly fine 0.71%.
Shares of Becton, Dickinson and closed today at $255.18 and stepped up a slightly fine 0.71%. Since price and SMA200d lines crossed up on August/6, BDX climbed $18.84 (7.97%). Since SMA100d and SMA200d crossed up on June, BDX price climbed $16.59 per share (6.95%).
Becton, Dickinson and escalated a decent 2.76% this week.
Price pattern shows an uptrend with two rising tops and bottoms, and now trading upwards to the $258.06 resistance. Since price and SMA40w lines crossed up by mid June, BDX climbed $21.02 (8.98%). Since SMA20d and SMA40w crossed up late May, BDX price climbed $27.55 per share (12.10%). Far behind is the all-time high Becton, Dickinson and hit early October but price is just -3.10% below that top.
BDX stock price history
BDX stock historical price chart
BDX stock reached all-time highs on October with a price of $263.35.
BDX stock price target is $263.40Nobody can reliably foresee how stock prices may evolve in the future. However, financial institutions invest time and resources to provide the most accurated estimations to help investors to make their decisions. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. We detected 13 price forecasts for Becton, Dickinson and stock posted in the last month:
|Date||Analyst / Broker||Action||Previous target||Current target||Diff|
|2019-8-6||Piper Jaffray Companies||Reiterates||$267.00||$266.00||-0.4%|
|2019-7-16||Morgan Stanley||Raises Target||$250.00||$261.00||4.4%|
|2019-6-28||Raymond James||Raises Target||$265.00||$288.00||8.7%|
|2019-5-13||Wells Fargo & Co||Reiterates||$280.00||$265.00||-5.4%|
|2019-5-10||UBS Group||Lowers Target||$265.00||$250.00||-5.7%|
|2019-5-10||Morgan Stanley||Lowers Target||$255.00||$250.00||-2%|
|2019-3-19||Raymond James||Lowers Target||$290.00||$280.00||-3.4%|
|2019-2-5||Piper Jaffray Companies||Raises Target||n/a||$274.00||-|
|2019-1-2||Morgan Stanley||Lowers Target||$265.00||$240.00||-9.4%|
Financials and fundamental analysis
Earnings date and Earnings per ShareOn February, Becton, Dickinson and presented its financial report, in line with analysts' consensus and published a $2.70 Earnings per Share. Unfortunately, reported EPS is not yet available in our database.
|Quarter||Reporting date||Estimated EPS||Actual EPS||Surprise|
Annual financial resultsIn 2018, Becton, Dickinson and annual revenues boosted an exceptional 32.17% to $15,983.00 M dollars from $12,093.00 marked in 2017. However, its profit margin (compared to revenues) fell to 1.95%, that is $311.00 million. Becton, Dickinson and fiscal year ends in September, and to evaluate its evolution since then, we estimate annual sales and income figures by adding results from the last 4 quarters. This is called TTM (or Twelve Trailing Months). So, Becton, Dickinson and TTM sales up to December 2018 were $17,062.00 and income $1,046.00 M dollars. If we compare this TTM figures with the last reported annuality, we can review Becton, Dickinson and business evolution since September 2018: Annual sales up to December, compared to lastest yearly report, jumped a more than good 6.75%. Regarding profit margin, Becton, Dickinson and raised 4.18% to 1.95%
|2013||$8,050 M||-||$929 M11.5%||-|
|2014||$8,446 M||4.92%||$1,185 M14.0%||27.56%|
|2015||$10,282 M||21.74%||$695 M6.8%||-41.35%|
|2016||$12,483 M||21.41%||$976 M7.8%||40.43%|
|2017||$12,093 M||-3.12%||$1,100 M9.1%||12.70%|
|2018||$15,983 M||32.17%||$311 M1.9%||-71.73%|
|TTM||$17,062 M||6.75%||$1,046 M6.1%||236.33%|
Quarterly financial resultsBecton, Dickinson and posted $4,160.00 M in sales for 2018-Q4, a -5.50% less compared to previous quarter. Reported quarter earnings marked $599.00 million with a profit margin of 14.40%. Profit margin skyrocketed a 17.47% compared to previous quarter when profit margin was -3.07%. When comparing revenues to same quarter last year, Becton, Dickinson and sales marked an outstanding gain and climbed a 35.06%.
|2017-Q1||$2,970 M||-||$344 M11.6%||-|
|2017-Q2||$3,040 M||2.36%||$-132 M-4.3%||-138.37%|
|2017-Q3||$3,166 M||4.14%||$327 M10.3%||-347.73%|
|2017-Q4||$3,080 M||-2.72%||$-136 M-4.4%||-141.59%|
|2018-Q1||$4,222 M||37.08%||$-12 M-0.3%||-91.18%|
|2018-Q2||$4,278 M||1.33%||$594 M13.9%||-5,050.00%|
|2018-Q3||$4,402 M||2.90%||$-135 M-3.1%||-122.73%|
|2018-Q4||$4,160 M||-5.50%||$599 M14.4%||-543.70%|
Becton, Dickinson and ownershipWhen you are planning to invest in a stock, it's worth to overview its ownership structure.
Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Becton, Dickinson and, 0.26% of all outstanding shares are owned by its staff.
Bearish positions for BDX stock account 0.00%, no big difference from last month.
The following table compares ownership indicators for other stocks related to Becton, Dickinson and:
|Market cap||$68.8 B||$44.5 B||$8.5 B||$104.0 M||$13.5 B|
|Total shares||269.7 M||510.2 M||24.7 M||37.7 M||268.1 M|
|Float shares||269.1 M||509.5 M||21.3 M||28.5 M||266.1 M|
|- Institutional holdings (%)||87.5%||88.2%||78.0%||74.1%||99.7%|
|- Insider holdings (%)||0.3%||0.1%||14.6%||12.9%||0.3%|
|Shares in short selling||0.0%||0.0%||0.0%||0.0%||0.0%|
|Thursday, August 22nd, 2019|
|Day range||$253.96 - $257.09|
|Average true range||$6.58|
|50d mov avg||$249.69|
|100d mov avg||$242.82|
|200d mov avg||$240.54|
Becton, Dickinson and performanceTo better understand Becton, Dickinson and performance you must becnhmark its gains with other related stocks in same sector or industry. We chose Baxter International, Bio-Rad Laboratories, Harvard Bioscience, Hologic, Intuitive Surgical, ResMed, Teleflex, Thermo Fisher Scientific, Varian Medical Systems and DENTSPLY SIRONA as the bechmarking frame for Becton, Dickinson and stock.
|TMOThermo Fisher Sci...||2.45%||10.53%||18.89%|
|VARVarian Medical Sy...||-15.24%||-18.40%||-3.48%|